Mechanism of Sodium Channel Block by Venlafaxine in Guinea Pig Ventricular Myocytes
Authors:
- Pascal DaleauPDPascal Daleau
- Jacques TurgeonJTJacques Turgeon
- 1 October 1999
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 291 (1) , 280-284
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Absolute Bioavailability and Electroencephalographic Effects of Conventional and Extended‐Release Formulations of Venlafaxine in Healthy SubjectsThe Journal of Clinical Pharmacology, 1998
- Seizures, Ventricular Tachycardia, and Rhabdomyolysis as a Result of Ingestion of Venlafaxine and LamotrigineAnnals of Emergency Medicine, 1997
- A Molecular and Cellular Theory of DepressionArchives of General Psychiatry, 1997
- The insertion allele at the angiotensin I—Converting enzyme gene locus is associated with insulin resistanceMetabolism, 1997
- Role of CYP2D6 in the Demethylation of Fluoxetine In VivoClinical Pharmacology & Therapeutics, 1996
- Pharmacological modulation of human cardiac Na+ channelsEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Introduction of a Composite Parameter to the Pharmacokinetics of Venlafaxine and its Active O‐Desmethyl MetaboliteThe Journal of Clinical Pharmacology, 1992
- Clinical Implications of the Competitive Inhibition of the Debrisoquin-Metabolizing Isozyme by QuinidineArchives of internal medicine (1960), 1991
- Detection of Depressive Disorder for Patients Receiving Prepaid or Fee-for-Service CareJAMA, 1989
- Sodium channel-blocking properties of flecainide, a class IC antiarrhythmic drug, in guinea-pig papillary muscles An open channel blocker or an inactivated channel blockerNaunyn-Schmiedeberg's Archives of Pharmacology, 1989